Recombinant Barmah forest virus Structural polyprotein, partial

Shipped with Ice Packs
In Stock

Description

Definition and Genomic Context

Recombinant Barmah Forest virus (BFV) Structural polyprotein, partial, refers to a genetically engineered protein fragment derived from the structural polyprotein of BFV. This polyprotein is encoded by the second open reading frame (ORF) of the BFV genome, which is expressed via a subgenomic RNA transcript . The full structural polyprotein undergoes proteolytic processing to generate mature viral structural proteins, including the capsid (C), envelope glycoproteins (E3, E2, and E1), and the small 6K protein . The "partial" designation indicates that the recombinant protein represents a specific domain or truncated segment of this polyprotein, typically used for research purposes such as antibody production, structural studies, or functional assays .

Applications in Research

Recombinant BFV structural polyprotein fragments are utilized in:

  • Antiviral Development: Mapping epitopes for vaccine design .

  • Structural Biology: Cryo-electron microscopy studies of E1-E2 spike architecture .

  • Diagnostics: Antigenic material for serological assays .

Challenges and Research Gaps

  • Structural Complexity: The partial polyprotein’s conformational flexibility complicates crystallization for high-resolution structural studies .

  • Functional Redundancy: Overlapping roles of E3, 6K, and E1 in virion assembly require further dissection .

  • Host Interactions: The role of host G3BP proteins in BFV replicase activity remains underexplored compared to other alphaviruses .

References

  1. Molecular tools for BFV pathogenesis studies (PMC11323547).

  2. Role of G3BP in alphavirus replication (PMC7081891).

  3. Cryo-EM structure of BFV (PMC3165765).

  4. Link between G3BP and replicase activity (JVI.01681-19).

  5. nsP4 replicase compatibility (JVI.00355-21).

  6. Structural polyprotein processing (PMC5580485).

  7. Commercial recombinant protein (ChemicalBook).

  8. Phylogenetic analysis of BFV (MDPI Viruses).

  9. E1-E2 spike architecture (ACS Publications).

Product Specs

Buffer
For liquid delivery forms, the default storage buffer is a Tris/PBS-based buffer containing 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer used prior to lyophilization is a Tris/PBS-based buffer containing 6% Trehalose.
Form
Liquid or Lyophilized powder
Please note: We will prioritize shipping the format currently in stock. However, if you have a specific format preference, please indicate it in your order notes. We will prepare your order according to your requirement.
Lead Time
3-7 business days
Notes
Repeated freezing and thawing is not recommended. For optimal results, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle to the bottom. Reconstitute the protein in deionized sterile water to a final concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% and can be used as a reference.
Shelf Life
The shelf life of the product is influenced by several factors, including storage conditions, buffer composition, storage temperature, and the inherent stability of the protein. Generally, the shelf life of the liquid form is 6 months at -20°C/-80°C. The lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
N-terminal 10xHis-tagged
Synonyms
Structural polyprotein; p130
Datasheet & Coa
Please contact us to get it.
Expression Region
801-1239aa
Mol. Weight
50.7 kDa
Protein Length
partial
Purity
Greater than 85% as determined by SDS-PAGE.
Research Area
Immunology
Source
in vitro E.coli expression system
Species
Barmah forest virus (BFV)
Target Names
N/A
Target Protein Sequence
YEHSTTMPNQVGIPFKALIERPGYAGLPLSLVVIKSELVPSLVQDYITCNYKTVVPSPYIKCCGGAECSHKNEADYKCSVFTGVYPFMWGGAYCFCDTENSQMSEVYVTRGESCEADHAIAYQVHTASLKAQVMISIGELNQTVDVFVNGDSPARIQQSKFILGPISSAWSPFDHKVIVYRDEVYNEDYAPYGSGQAGRFGDIQSRTVNSTDVYANTNLKLKRPASGNVHVPYTQTPSGFSYWKKEKGVPLNRNAPFGCIIKVNPVRAENCVYGNIPISMDIADAHFTRIDESPSVSLKACEVQSCTYSSDFGGVASISYTSNKVGKCAIHSHSNSATMKDSVQDVQESGALSLFFATSSVEPNFVVQVCNARITCHGKCEPPKDHIVPYAAKHNDAEFPSISTTAWQWLAHTTSGPLTILVVAIIVVVVVSIVVCARH
Note: The complete sequence including tag sequence, target protein sequence and linker sequence could be provided upon request.
Uniprot No.

Target Background

Function
The Barmah Forest virus structural polyprotein, partial, forms an icosahedral capsid with a T=4 symmetry. This capsid comprises 240 copies of the capsid protein, surrounded by a lipid membrane. The membrane is penetrated by 80 spikes composed of trimers of E1-E2 heterodimers. The capsid protein interacts with the viral RNA genome at a site adjacent to the ribosome binding site for viral genome translation following genome release. It exhibits protease activity, leading to its autocatalytic cleavage from the nascent structural protein. After self-cleavage, the capsid protein transiently associates with ribosomes. Within minutes, the protein binds to viral RNA and rapidly assembles into icosahedral core particles. The resulting nucleocapsid subsequently associates with the cytoplasmic domain of the spike glycoprotein E2 at the cell membrane, culminating in budding and the formation of mature virions. Upon infection, newly formed virions attach to target cells. After clathrin-mediated endocytosis, their membrane fuses with the host endosomal membrane, releasing the nucleocapsid into the cytoplasm. This release is followed by an uncoating event essential for the genomic RNA to become accessible. Uncoating may be triggered by the interaction of capsid proteins with ribosomes. The binding of ribosomes could release the genomic RNA, as the same region serves as both genomic RNA-binding and ribosome-binding sites. This protein specifically inhibits interleukin-1 receptor-associated kinase 1/IRAK1-dependent signaling during viral entry, potentially representing a mechanism by which alphaviruses evade innate immune detection and activation prior to viral gene expression. The protein provides the signal sequence for the translocation of the precursor of protein E3/E2 to the host endoplasmic reticulum. Furin-cleaved E3 remains associated with spike glycoprotein E1 and mediates pH protection of the latter during transport via the secretory pathway. After virion release from the host cell, the assembly protein E3 is gradually released into the extracellular space. The E2 protein plays a role in viral attachment to target host cells by binding to the cell receptor. It is synthesized as a p62 precursor, which is processed by furin at the cell membrane just before virion budding, resulting in the formation of the E2-E1 heterodimer. The p62-E1 heterodimer is stable, while E2-E1 is unstable and dissociates at low pH. p62 undergoes processing in the final step, presumably to prevent E1 fusion activation before its final export to the cell surface. The E2 C-terminus contains a transitory transmembrane domain that is disrupted by palmitoylation, causing reorientation of the C-terminal tail from the lumenal to the cytoplasmic side. This step is critical, as the E2 C-terminus interacts with capsid proteins during budding. This release of the E2 C-terminus in the cytoplasm occurs late in protein export, preventing premature assembly of particles at the endoplasmic reticulum membrane. The 6K protein is a constitutive membrane protein involved in virus glycoprotein processing, cell permeabilization, and the budding of viral particles. It disrupts the calcium homeostasis of the cell, likely at the endoplasmic reticulum level, leading to cytoplasmic calcium elevation. Due to its lipophilic properties, the 6K protein is thought to influence the selection of lipids that interact with the transmembrane domains of the glycoproteins. This, in turn, affects the deformability of the bilayer required for the extreme curvature that occurs during budding. The 6K protein is present in low amounts in virions, approximately 3% compared to viral glycoproteins. The E1 protein is a class II viral fusion protein. Its fusion activity remains inactive as long as E1 is bound to E2 in the mature virion. After virus attachment to the target cell and endocytosis, acidification of the endosome triggers the dissociation of the E1/E2 heterodimer and subsequent trimerization of the E1 subunits. This E1 trimer becomes fusion-active, promoting the release of the viral nucleocapsid into the cytoplasm after endosome and viral membrane fusion. Efficient fusion requires the presence of cholesterol and sphingolipids in the target membrane. Fusion is optimal at levels of approximately 1 molecule of cholesterol per 2 molecules of phospholipids and is specific for sterols containing a 3-beta-hydroxyl group.
Database Links

KEGG: vg:1489701

Subcellular Location
[Capsid protein]: Virion. Host cytoplasm. Host cell membrane. Host nucleus.; [Spike glycoprotein E2]: Virion membrane; Single-pass type I membrane protein. Host cell membrane; Single-pass type I membrane protein.; [6K protein]: Host cell membrane; Multi-pass membrane protein. Virion membrane; Multi-pass membrane protein.; [Spike glycoprotein E1]: Virion membrane; Single-pass type I membrane protein. Host cell membrane; Single-pass type I membrane protein.

Q&A

What is the basic structure of Barmah Forest virus and its structural polyprotein?

Barmah Forest virus exhibits a typical alphavirus organization as revealed by cryo-electron microscopy at 6-Å resolution . The virus consists of an RNA-containing nucleocapsid surrounded by a bilipid membrane anchored with the surface proteins E1 and E2 . The structural polyprotein is processed to form the capsid protein and envelope glycoproteins that comprise the virus particle.

Key structural features include:

  • The transmembrane regions of E1 and E2 glycoproteins are clearly visible in structural studies

  • The C-terminal end of the E2 transmembrane helix binds to the capsid protein

  • Following the E2 transmembrane helix, a short α-helical endodomain lies on the inner surface of the lipid envelope

  • The E2 endodomain interacts with E1 transmembrane helix from a neighboring E1-E2 trimeric spike, serving as a spacer and linker between spikes

These structural elements play crucial roles in virus assembly, with the endodomain particularly important in recruiting other E1-E2 spikes to the budding site during virus formation .

How does BFV infection present clinically and how does it compare to related alphaviruses?

BFV infection in humans results in symptoms similar to but generally milder than those caused by Ross River virus . The clinical presentation includes:

  • Rash (commonly on face and body)

  • Fever

  • Muscle tenderness and myalgia

  • Polyarthritis and arthralgia

  • Headache

  • Nausea

While the fever typically resolves within a week, muscle and joint pain may persist for more than six months in some cases . This prolonged morbidity makes BFV an infection of public health concern, particularly in endemic regions. The clinical similarity to other alphavirus infections, especially Ross River virus, presents a diagnostic challenge for clinicians and researchers alike, highlighting the importance of specific laboratory confirmation methods.

What evolutionary patterns have been observed in BFV structural proteins and how do they compare to other alphaviruses?

Recent research using stochastic mapping and discrete-trait phylogenetic analyses has revealed fascinating evolutionary patterns in BFV, particularly when compared to Ross River virus (RRV) . Analysis of 186 RRV and 88 BFV genomes demonstrated that these viruses have undergone convergent evolution, with repeated selection of mutations particularly in the nonstructural protein 1 (nsP1) and envelope 3 (E3) genes .

The convergent mutations observed in the E3 proteins (RRV site 59 and BFV site 57) may be associated with enzymatic furin activity and cleavage of E3 from protein precursors that assist in viral maturation and infectivity . This convergent evolution in both viruses suggests a dynamic link between their requirement to selectively "fine-tune" intracellular host interactions and viral replicative enzymatic processes .

Despite this evidence of evolutionary convergence, selection pressure analyses did not reveal any BFV amino acid sites under strong positive selection, with only weak positive selection detected for nonstructural protein sites . This suggests that BFV ancestors were subject to positive selection events that predisposed ongoing pervasive convergent evolution, while contemporary populations are primarily under purifying selection during replication in mosquito and vertebrate hosts .

What methodological approaches are optimal for expressing and purifying recombinant BFV structural polyprotein?

For researchers working with recombinant BFV structural polyprotein, several methodological considerations are important:

  • Expression Systems: Based on approaches used with related alphaviruses, mammalian cell lines (such as BHK-21, Vero) or insect cell lines (Sf9, Hi5) with baculovirus expression systems are recommended for proper folding and post-translational modifications of BFV structural proteins.

  • Constructs Design: When designing expression constructs, researchers should consider:

    • Including only the partial polyprotein region of interest rather than the complete structural polyprotein

    • Incorporating appropriate signal sequences for secretion if working with the ectodomains

    • Adding purification tags (His-tag, GST) that minimally interfere with protein folding

  • Purification Strategy: A multi-step purification approach is typically required:

    • Initial capture using affinity chromatography (if tags are incorporated)

    • Intermediate purification using ion exchange chromatography

    • Final polishing using size exclusion chromatography to ensure homogeneity

  • Quality Control: Structural and functional verification through:

    • Western blotting with BFV-specific antibodies

    • Mass spectrometry to confirm protein identity

    • Circular dichroism to assess secondary structure

    • Dynamic light scattering to assess homogeneity and aggregation state

These methodological considerations are essential for obtaining properly folded and biologically relevant recombinant BFV structural proteins for downstream applications.

How do the transmembrane domains of BFV E1 and E2 glycoproteins contribute to virus assembly and host cell interaction?

Cryo-electron microscopy studies have provided valuable insights into the roles of BFV E1 and E2 transmembrane domains in virus assembly and host interactions . The transmembrane regions of E1 and E2 are not merely anchors but play active roles in the virus life cycle:

  • E2 Transmembrane Helix: The C-terminal end of this helix binds directly to the capsid protein, creating a critical link between the envelope and nucleocapsid components of the virus .

  • E2 Endodomain: Following the transmembrane helix, a short α-helical endodomain lies on the inner surface of the lipid envelope. This domain interacts with the E1 transmembrane helix from neighboring E1-E2 trimeric spikes, functioning as both a spacer and a linker between spikes .

  • Assembly Coordination: The E2 endodomain plays a crucial role in recruiting other E1-E2 spikes to the budding site during virus assembly, as confirmed by mutagenesis studies .

  • Host Membrane Interactions: The transmembrane regions facilitate interactions with host cell membranes during both entry and budding processes.

These structural features represent potential targets for antiviral strategies and are critical consideration points for researchers designing recombinant constructs or studying virus-host interactions.

What genetic lineages of BFV have been identified and what are their distinguishing molecular features?

Phylogenetic analyses of BFV have revealed multiple genetic lineages with distinct molecular characteristics:

LineageGeographical DistributionKey Genetic FeaturesYear(s) Detected
Lineage 1Mainland AustraliaReference strain type1974-present
Lineage 2Eastern AustraliaDivergence in E2 gene and 3′ UTR2017-2018
Lineage 3Papua New GuineaDistinct from Australian isolates2014-present

Understanding these genetic lineages is essential for researchers studying BFV evolution, transmission dynamics, and potential variations in virulence or host tropism.

What are the molecular mechanisms underlying the convergent evolution observed in BFV and RRV structural and non-structural proteins?

The observed convergent evolution in BFV and RRV, particularly in nsP1 and E3 genes, offers fascinating insights into alphavirus adaptation mechanisms :

This convergent evolution likely represents adaptive responses to the requirement of these viruses to replicate in disparate insect and vertebrate hosts, enabling them to "fine-tune" intracellular host interactions and viral replicative enzymatic processes .

What are recommended approaches for studying BFV structural polyprotein in different host cell systems?

When designing experiments to study BFV structural polyprotein in different host systems, researchers should consider the following approaches:

  • Comparative Host Cell Systems:

    • Mosquito cells (C6/36, Aag2): Represent the arthropod vector environment

    • Mammalian cells (Vero, BHK-21, human cell lines): Model vertebrate host environments

    • Avian cells: Potential alternative hosts for studying host range restrictions

  • Investigation Methods:

    • Infection studies with wild-type or recombinant BFV to track polyprotein processing kinetics

    • Transfection of expression constructs encoding partial or complete structural polyprotein

    • Pulse-chase experiments to monitor polyprotein processing and trafficking

    • Confocal microscopy with fluorescently tagged proteins to visualize localization patterns

    • Co-immunoprecipitation to identify host factors interacting with structural proteins

  • Temperature Effects: Conducting parallel experiments at different temperatures (28°C for mosquito-relevant conditions and 37°C for mammalian-relevant conditions) to assess temperature-dependent effects on protein folding, processing, and function.

  • Comparative Analysis Framework:

ParameterMosquito Cell SystemMammalian Cell SystemAnalytical Method
Processing kineticsOften slowerTypically fasterPulse-chase, Western blot
Glycosylation patternsDifferent glycan structuresComplex glycosylationMass spectrometry, lectin blots
Intracellular traffickingMay use different pathwaysFollows canonical secretory pathwayConfocal microscopy, subcellular fractionation
Host restriction factorsIdentify mosquito-specific factorsIdentify mammalian-specific factorsRNA-Seq, proteomics, siRNA screening

These approaches allow for systematic comparison of BFV structural polyprotein behavior across host systems, providing insights into host adaptation mechanisms.

What structural analysis techniques are most effective for studying recombinant BFV proteins?

Multiple complementary structural analysis techniques are recommended for comprehensive characterization of recombinant BFV structural proteins:

Integration of multiple techniques provides complementary insights into BFV structural proteins, overcoming limitations of individual methods and building a comprehensive structural understanding.

How can researchers effectively compare BFV structural proteins from different viral lineages?

To effectively compare BFV structural proteins from different viral lineages, researchers should implement a multi-faceted approach:

  • Sequence-Based Comparisons:

    • Multiple Sequence Alignment: Identify conserved and variable regions across lineages

    • Phylogenetic Analysis: Construct trees based on structural protein sequences to establish evolutionary relationships

    • Selection Pressure Analysis: Apply methods like FUBAR, SLAC, MEME, and GenomegaMap to identify sites under positive or purifying selection

    • Ancestral Sequence Reconstruction: Infer evolutionary paths that led to lineage divergence

  • Experimental Comparative Analysis:

    • Recombinant Expression: Generate corresponding proteins from different lineages under identical conditions

    • Structural Comparison: Compare folding, stability, and 3D structures

    • Functional Assays: Compare:

      • Receptor binding properties

      • Fusion activity under various pH conditions

      • Antibody neutralization profiles

      • Host cell tropism

  • Chimeric Protein Approach:

    • Engineer chimeric proteins containing regions from different lineages to map functional domains

    • Use these chimeras to identify regions responsible for phenotypic differences between lineages

  • Table 2: Recommended Analytical Framework for BFV Lineage Comparison

Analysis LevelMethodsExpected Insights
Primary sequenceAlignment, conservation analysisIdentify lineage-specific signatures
Secondary/tertiary structureCD spectroscopy, crystallography, cryo-EMDetect structural differences
Host interactionCell binding assays, SPRCompare receptor usage and binding kinetics
Immunological propertiesNeutralization assays, epitope mappingIdentify differential antibody recognition
Entry and fusionVirus entry assays, fusion-from-without assaysCompare fusion triggering conditions
Vector competenceInfection of different mosquito species/cellsIdentify vector specificity differences

This comprehensive approach enables researchers to connect sequence divergence with functional consequences, providing insights into BFV evolution and host adaptation.

How can recombinant BFV structural proteins contribute to vaccine development strategies?

Recombinant BFV structural proteins offer several promising avenues for vaccine development research:

  • Subunit Vaccine Approaches:

    • Recombinant E1 and E2 glycoproteins as immunogens

    • Virus-like particles (VLPs) formed by co-expression of capsid and envelope proteins

    • Chimeric proteins incorporating protective epitopes from multiple alphavirus species

  • Rational Antigen Design Strategies:

    • Structure-guided stabilization of E1/E2 in their pre-fusion conformation

    • Glycan engineering to enhance immunogenicity while maintaining proper folding

    • Presentation of conserved neutralizing epitopes while minimizing exposure of non-neutralizing epitopes

  • Cross-Protection Potential:

    • Assessment of cross-reactivity between BFV antigens and antibodies against related alphaviruses

    • Identification of conserved epitopes that might provide broader protection against multiple alphaviruses

    • Design of consensus immunogens based on sequence alignment of different BFV lineages

  • Delivery Systems Optimization:

    • Lipid nanoparticle formulations for mRNA vaccines encoding BFV structural proteins

    • Viral vector platforms (adenovirus, modified vaccinia Ankara) expressing BFV antigens

    • Adjuvant screening to enhance immunogenicity while minimizing reactogenicity

  • Table 3: Pros and Cons of Different BFV Vaccine Approaches

ApproachAdvantagesChallengesResearch Needs
Recombinant E1/E2 proteinsDefined composition, safetyMay lack proper conformationStabilization strategies
Virus-like particlesNative-like structure, potent immunogensComplex productionScalable manufacturing processes
mRNA vaccinesRapid development, in vivo expressionCold chain requirementsOptimization for alphavirus antigens
Chimeric/consensus antigensPotential cross-protectionMay lose crucial epitopesCareful immunological validation

While BFV disease may not have the global health impact of some other alphaviruses, research on its structural proteins contributes valuable insights applicable to broader alphavirus vaccine strategies, including for more widespread threats like chikungunya virus.

What are the major knowledge gaps in understanding BFV structural protein interactions with host and vector cells?

Despite advances in BFV research, several critical knowledge gaps remain regarding structural protein interactions with hosts and vectors:

  • Receptor Identification and Binding Mechanisms:

    • The specific receptors used by BFV to enter host and vector cells remain unidentified

    • The binding sites on E2 glycoprotein that mediate receptor recognition are undefined

    • The conformational changes in structural proteins following receptor binding are poorly characterized

  • Vector-Virus Interactions:

    • Limited understanding of structural protein modifications in mosquito versus vertebrate hosts

    • Incomplete knowledge of how BFV structural proteins interact with mosquito immune mechanisms

    • Unknown basis for vector specificity (why certain mosquito species transmit BFV more efficiently)

  • Pathogenesis Mechanisms:

    • The role of structural proteins in tissue tropism and arthritogenic disease is not fully elucidated

    • Incomplete understanding of how structural protein variations between lineages might affect virulence

    • Limited knowledge of how structural proteins contribute to immune evasion strategies

  • Evolutionary Dynamics:

    • Unclear selective pressures driving convergent evolution in E3 proteins

    • Limited understanding of how structural protein evolution contributes to host range expansion

    • Insufficient data on how recent lineage diversification affects antigenic properties

  • Research Priorities Table:

Knowledge GapResearch ApproachExpected Impact
Receptor identityCRISPR screens, glycan arrays, proximity labelingNew antiviral targets
Structural changes during entryTime-resolved cryo-EM, FRET-based sensorsImproved understanding of fusion mechanism
Vector-specific modificationsComparative glycoproteomics, structure determination in mosquito cellsVector control strategies
Lineage-specific virulence factorsReverse genetics with chimeric virusesRisk assessment tools
Convergent evolution mechanismsDeep mutational scanning, ancestral reconstructionPrediction of emerging variants

Addressing these knowledge gaps will not only advance understanding of BFV biology but may also provide broader insights applicable to other medically important alphaviruses.

How might climate change affect the evolution and distribution of BFV strains, and what methodological approaches can address this question?

Climate change is likely to significantly impact BFV evolution and distribution through multiple mechanisms. Researchers can investigate these effects through integrated methodological approaches:

  • Vector Ecology and Distribution Changes:

    • Methodological Approach: Combine climate modeling with vector surveillance data to predict expanding mosquito habitats

    • Research Question: How will changing temperatures affect the geographical range of competent vectors like Culex annulirostris and Aedes vigilax?

    • Experimental Design: Field sampling across climate gradients combined with controlled laboratory studies on vector competence under different temperature regimes

  • Viral Adaptation to New Environmental Conditions:

    • Methodological Approach: Experimental evolution studies exposing BFV to fluctuating temperature conditions

    • Research Question: How do BFV structural proteins adapt to new thermal environments, and does this affect viral fitness in different hosts?

    • Analytical Technique: Deep sequencing to identify adaptive mutations in structural proteins following environmental stress

  • Host-Range Expansion:

    • Methodological Approach: Survey potential vertebrate reservoir hosts in areas of predicted climate-driven range expansion

    • Research Question: Will changing climate facilitate BFV adaptation to new host species through structural protein evolution?

    • Technique: Serosurveillance combined with in vitro assessment of BFV replication in cells derived from potential new host species

  • Lineage Distribution and Competition:

    • Methodological Approach: Longitudinal genomic surveillance across geographical and climate gradients

    • Research Question: Will climate change alter the competitive dynamics between different BFV lineages?

    • Analysis Framework: Mathematical modeling integrating climate data, vector biology, and viral molecular evolution

  • Table 4: Climate Variables and Their Potential Impact on BFV Evolution

Climate VariableVector EffectViral AdaptationResearch Methods
Temperature increaseExtended transmission seasonSelection for thermal stability in structural proteinsThermal stability assays of recombinant proteins
Rainfall pattern changesNew breeding habitatsPotential adaptation to new vector speciesVector competence studies with emerging mosquito species
Extreme weather eventsPopulation bottlenecksGenetic drift in structural genesPhylodynamic analysis before/after extreme events
Sea level riseCoastal mosquito habitat expansionSelection in coastal lineagesComparative genomics of coastal vs. inland isolates

This multidisciplinary approach combining field surveillance, laboratory experimentation, and computational modeling provides a framework for understanding and potentially predicting how climate change will affect BFV evolution and emergence risk.

What are the optimal conditions for expressing and purifying different domains of BFV structural polyprotein?

Expression and purification of BFV structural protein domains require careful optimization depending on the specific domain and research objectives:

  • E1 Glycoprotein Domains:

    • Ectodomain: Best expressed in mammalian cells (HEK293, CHO) with C-terminal trimerization domain

    • Fusion Peptide Region: Challenging due to hydrophobicity; consider peptide synthesis or fusion with solubility-enhancing partners

    • Transmembrane Domain: Requires detergent or nanodisc systems; consider MISTIC fusion strategy

  • E2 Glycoprotein Domains:

    • Receptor Binding Domain: Amenable to expression in insect cells with proper glycosylation sites

    • Domain B: Relatively soluble and can be expressed as isolated domain in E. coli

    • Stem Region: Challenging; consider synthetic peptide approaches

  • Capsid Protein:

    • N-terminal RNA-binding Domain: Soluble in E. coli expression systems

    • C-terminal Protease Domain: Well-expressed in bacterial systems

  • Buffer and Additive Optimization Table:

Protein DomainOptimal Buffer CompositionCritical AdditivesStorage Conditions
E1 ectodomain20 mM Tris pH 8.0, 150 mM NaCl10% glycerol, 0.5 mM EDTA-80°C; avoid freeze-thaw
E2 ectodomain20 mM HEPES pH 7.5, 150 mM NaCl5% sucrose-80°C with protease inhibitors
E1/E2 heterodimerPBS pH 7.41 mM CaCl₂, 5% glycerol4°C for short-term; -80°C long-term
Capsid protein50 mM HEPES pH 7.0, 300 mM NaCl2 mM DTT-20°C with glycerol
  • Quality Control Metrics:

    • Thermal shift assays to confirm proper folding

    • Size exclusion chromatography to assess aggregation state

    • Glycoprotein analysis to confirm proper post-translational modifications

    • Functional binding assays where applicable

These optimized conditions should be considered starting points and further refined based on specific research needs and protein constructs.

What are the key controls and validation steps for experiments involving recombinant BFV structural proteins?

Rigorous controls and validation steps are essential for experiments with recombinant BFV structural proteins:

  • Protein Quality Validation:

    • Identity Confirmation: Mass spectrometry analysis to confirm primary sequence

    • Purity Assessment: SDS-PAGE with multiple staining methods (Coomassie, silver stain)

    • Homogeneity Verification: Size exclusion chromatography and dynamic light scattering

    • Structural Integrity: Circular dichroism to confirm secondary structure content matches predictions

  • Functional Validation Controls:

    • Positive Controls: Include well-characterized related alphavirus proteins (e.g., from Sindbis or chikungunya viruses)

    • Negative Controls: Use denatured protein preparations to distinguish specific from non-specific effects

    • Dosage Controls: Perform experiments with multiple protein concentrations to establish dose-response relationships

  • Binding and Interaction Experiments:

    • Specificity Controls: Include irrelevant proteins of similar size/structure

    • Blocking Controls: Pre-incubation with antibodies or known ligands

    • Competition Assays: Displacement with unlabeled protein to confirm specific binding

  • Cell-Based Experiments:

    • Mock Controls: Include buffer-only and irrelevant protein controls

    • Cytotoxicity Assessment: Monitor cell viability to distinguish specific effects from general toxicity

    • Time Course Studies: Establish appropriate experimental timeframes

  • Validation Framework Table:

Experiment TypeEssential ControlsValidation MetricsRed Flags
Binding assaysNon-binding variant, competition controlsReproducible Kd valuesPrecipitation during assay, non-specific binding
Cell entry studiesTemperature controls (4°C vs. 37°C)Dose-dependent effectsEqual effects at 4°C and 37°C
Immunological studiesPre-immune sera, isotype controlsConsistent titration curvesHigh background with control samples
Structural studiesBuffer-only samples, related proteinsResolution statistics, Ramachandran plotsUnexplained electron density, poor model statistics
  • Reproducibility Measures:

    • Use multiple protein preparations from independent expressions

    • Perform technical and biological replicates

    • Validate key findings with complementary methodologies

Following these control and validation steps ensures robust, reliable data that advances understanding of BFV structural proteins while minimizing artifacts and misinterpretations.

How can researchers overcome challenges in working with the hydrophobic domains of BFV structural proteins?

The hydrophobic domains of BFV structural proteins, particularly the transmembrane regions and fusion peptides, present significant technical challenges. Here are strategies to overcome these difficulties:

  • Expression System Optimization:

    • Fusion Partners: Employ solubility-enhancing fusion partners such as:

      • SUMO tag for improved folding and solubility

      • MBP (maltose-binding protein) for increased expression and solubility

      • Thioredoxin for enhanced disulfide bond formation

    • Specialized Expression Systems:

      • Cell-free systems with added lipids or detergents

      • MISTIC (Membrane-Integrating Sequence for Translation of Integral membrane protein Constructs) for bacterial expression

      • Baculovirus expression for complex membrane proteins

  • Membrane Mimetic Systems:

    • Detergent Selection: Systematic screening of detergents:

      • Mild detergents (DDM, LMNG) for initial extraction

      • Fluorinated detergents for maintaining native structure

    • Lipid Nanodisc Technology: Incorporation into nanodiscs with native-like lipid composition

    • Styrene Maleic Acid Lipid Particles (SMALPs): Direct extraction from membranes without detergents

  • Construct Design Strategies:

    • Domain Boundaries: Careful bioinformatic analysis to identify optimal domain boundaries

    • Truncation Series: Create multiple constructs with systematic truncations

    • Chimeric Approaches: Replace highly hydrophobic regions with homologous but more soluble regions from related viruses

  • Stabilization Strategies:

    • Disulfide Engineering: Introduce strategic disulfide bonds to stabilize tertiary structure

    • Glycan Engineering: Add glycosylation sites to increase solubility

    • Thermostabilizing Mutations: Introduce point mutations identified through computational prediction or directed evolution

  • Table 5: Troubleshooting Hydrophobic Domain Challenges

ChallengeStrategyAdvantagesLimitations
Protein aggregationAddition of glycerol, arginine, or low concentrations of denaturantsSimple, inexpensiveMay affect functional assays
Low expression yieldCodon optimization, lower expression temperatureImproves foldingTime-consuming optimization
Detergent incompatibilitySystematic detergent screening, amphipol replacementIdentifies optimal conditionsExpensive, labor-intensive
Structure determination difficultiesAntibody fragment co-crystallization, thermostabilizationEnhances crystal contactsMay alter native conformation
Functional assessmentReconstitution into liposomes with native-like lipid compositionMimics natural environmentComplex to standardize

By implementing these strategies, researchers can overcome the inherent challenges of working with hydrophobic domains of BFV structural proteins, enabling more comprehensive structural and functional studies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.